Andrew M. Peseski

Journal article Thromb Res · January 2026 BACKGROUND: The indications for anticoagulation and the number of patients on anticoagulation is rising. Accordingly, adverse drug events related to anticoagulation use are on the rise and represents an opportunity for improvement in patient safety. About ... Full text Link to item Cite

Anticoagulation in malignancy: the patient who bleeds and clots simultaneously.

Journal article Hematology Am Soc Hematol Educ Program · December 5, 2025 Patients with active malignancy frequently require anticoagulation for a variety of indications, including thrombosis, atrial fibrillation, or mechanical heart valves. Cancer-associated thrombosis is associated with significant morbidity and mortality and ... Full text Link to item Cite

Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions.

Journal article Thromb Res · November 2025 INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality worldwide, prompting increasing use of antiplatelet agents for primary and secondary prevention. Despite guidelines from multiple professional societies on the perioperative manag ... Full text Link to item Cite

Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.

Journal article Blood Adv · April 8, 2025 Antithrombotic therapy can prevent recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE). It is, however, associated with an increased risk for major bleeding. This meta-analysis systematically reviewed the evidence regarding the duration of ant ... Full text Link to item Cite

Multimodal quality improvement project on reducing hospital perioperative thromboembolic events (Patient Safety Indicator-12).

Journal article BMJ Open Qual · April 3, 2025 BACKGROUND: Venous thromboembolism (VTE), which includes both pulmonary embolism and deep vein thrombosis, is a common yet significant postoperative complication. Patient Safety Indicator (PSI)-12 was introduced by Centers for Medicare & Medicaid Services ... Full text Link to item Cite

An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county.

Journal article Res Pract Thromb Haemost · May 2024 BACKGROUND: Cancer-associated venous thromboembolism (CA-VTE) represents a major cause of morbidity and mortality in patients with cancer. Despite poor outcomes, there is an ongoing knowledge gap in epidemiologic data related to this association. OBJECTIVE ... Full text Link to item Cite

Does Race Play a Role in Complications and Outcomes of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms?

Journal article Hematol Oncol Stem Cell Ther · June 1, 2022 BACKGROUND: Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are a group of hematologic malignancies with known vascular complications. The role race and ethnicity play in these complications is less defined. We aimed to further evaluate ... Full text Link to item Cite

Management of fever and neutropenia in the adult patient with acute myeloid leukemia.

Journal article Expert Rev Anti Infect Ther · March 2021 INTRODUCTION: Febrile neutropenia represents one of the most common treatment-associated complications in the management of acute myeloid leukemia (AML) and is considered an oncologic emergency. Rapid and detailed workup as well as the initiation of empiri ... Full text Link to item Cite

Case Report: Candida dubliniensis as a Cause of Chronic Meningitis.

Journal article Front Neurol · 2020 Background: Candida dubliniensis is closely related to Candida albicans and rarely isolated in clinical specimens. C. dubliniensis is increasingly recognized as a pathogen in immunocompromised hosts. We present the third known case of Candida dubliniensis ... Full text Link to item Cite